ImmunityBio converts from Immunomedics Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ImmunityBio converts from Immunomedics

IBRX 2.065

-2.1%

9:49 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

Recommended by:

erippetoe

From: luckydog88	6/2/2025 9:03:01 AM
	1 Recommendation of 1229

couple of deals in the biotech space this morning: BioNTech - The Germany-based biotech stock jumped 11.3% after Bristol Myers Squibb agreed to a multibillion-dollar deal, including a payment of $1.5 billion upfront, to partner with BioNTech to co-develop an experimental cancer drug. Bristol Myers Squibb rose 1%. Blueprint Medicines — The biopharma stock rallied nearly 27% after it struck an agreement to be acquired by Sanofi in an approximately $9.5 billion deal. Sanofi will pay $129 per share of Blueprint Medicines in cash, representing 27% upside from Friday’s close. Sanofi’s shares were down marginally.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next